| Lung Non-Squamous Non-Small Cell Carcinoma studied in …STUDIED_INderived200 of 408show all (up to 200) |
|---|
| → studied in | NCT03793179Phase 3 · active not recruiting Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181060Phase 3 · recruiting Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04267848Phase 3 · recruiting Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310007Phase 2 · active not recruiting Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489066Phase 2 · recruiting Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06491862recruiting RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627647Phase 3 · recruiting A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03965689Phase 2 · active not recruiting Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151574Phase 3 · active not recruiting Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03391869Phase 3 · active not recruiting Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05017025Phase 1/Phase 2 · completed Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04105270Phase 2 · recruiting RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821684Phase 3 · not yet recruiting A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04958811Phase 2 · active not recruiting Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06687369Phase 3 · active not recruiting A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906071Phase 3 · completed Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198830Phase 2 · active not recruiting Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602842Phase 1/Phase 2 · recruiting A Study of IDP-001 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07486817Phase 2 · recruiting Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739186Phase 2/Phase 3 · not yet recruiting A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05517811recruiting Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797168Phase 1/Phase 2 · recruiting Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557449Phase 2 · active not recruiting Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777822Phase 3 · recruiting Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07246863Phase 2 · recruiting Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929041Phase 2/Phase 3 · active not recruiting Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06416410Phase 3 · recruiting JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07098988Phase 2 · recruiting Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05258279Phase 2 · completed Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396065Phase 3 · active not recruiting Phase III Study of AK112 for NSCLC Patients · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796816NA · active not recruiting Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped PROBABILISTIC · 408 trials mapped (118 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06585488Phase 1 · terminated A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06939595Phase 3 · active not recruiting A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05887492Phase 1/Phase 2 · active not recruiting Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02193282Phase 3 · active not recruiting Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675876Phase 1 · not yet recruiting Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566432completed Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04084717Phase 2 · completed Study of Crizotinib for ROS1 and MET Activated Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636252recruiting Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07660094Phase 3 · recruiting Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07624487Phase 2 · recruiting Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03199651NA · recruiting Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647692not yet recruiting Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005102Phase 2/Phase 3 · recruiting A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07633626recruiting Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630246not yet recruiting CLINICAL STUDY TO IDENTIFY BIOMARKERS FOR TUMOR SPREAD THROUGH AIR SPACES STATUS · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06463665Phase 2 · recruiting Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05764954Phase 1 · active not recruiting A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843629recruiting Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06868836Phase 2 · recruiting Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485166active not recruiting Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05456256Phase 2 · recruiting A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05191485recruiting Shared Decision Making in Patients With Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05528458Phase 2 · recruiting Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03737994Phase 2 · terminated Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06491225Phase 1 · terminated Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04937283NA · recruiting Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06181812recruiting Pathogenic Variants in Genes Associated With Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06495125Phase 2 · recruiting Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481786Phase 3 · recruiting Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665504recruiting Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04432207Phase 1 · terminated A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479095NA · recruiting Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lepidic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012759recruiting Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07264816Phase 2 · recruiting A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05184712Phase 3 · active not recruiting Phase 3 Clinical Study of AK112 for NSCLC Patients · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07219251NA · recruiting Engagement of Veterans With Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03366766Phase 2 · terminated Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07423169NA · recruiting Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07235280early Phase 1 · recruiting Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416058Phase 2 · not yet recruiting PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392073not yet recruiting Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07229339Phase 2 · not yet recruiting Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383116Phase 3 · not yet recruiting Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339218Phase 3 · recruiting Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07373171NA · not yet recruiting Evaluation of Different Sizes of Left-Sided Double-Lumen Tubes for Thoracic Surgery in a Tertiary Level Teaching Hospital · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06879717Phase 1/Phase 2 · active not recruiting A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287904not yet recruiting Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285434early Phase 1 · enrolling by invitation Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07273279not yet recruiting ADH1B and ALDH Gene Variants and Lung Cancer Risk · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625647Phase 2 · active not recruiting Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07178795Phase 3 · recruiting A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468426Phase 1 · completed A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504916Phase 2 · terminated A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194735Phase 1/Phase 2 · terminated Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05558904Phase 1/Phase 2 · recruiting An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04524689Phase 2 · terminated Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05317078Phase 1 · terminated A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03184571Phase 2 · completed Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04619433Phase 3 · terminated A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC. · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169903Phase 3 · not yet recruiting Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737502Phase 1/Phase 2 · completed Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245071Phase 2 · terminated Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06505837Phase 3 · active not recruiting JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01951482Phase 3 · completed Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417008Phase 2/Phase 3 · recruiting A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292859completed Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299163Phase 1 · terminated NM32-2668 in Adult Patients With Selected Advanced Solid Tumors · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06643117Phase 3 · terminated Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04533451Phase 2 · active not recruiting Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06477211completed DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07002788NA · active not recruiting Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery. · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03299088Phase 1 · completed Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06953492completed Sleep State in Lung Cancer: A Retrospective Analysis · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03054298Phase 1 · completed CAR T Cells in Mesothelin Expressing Cancers · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04786964Phase 3 · terminated Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03676192Phase 3 · completed To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04032704Phase 2 · terminated A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858410Phase 3 · not yet recruiting Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04206787completed The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06847334Phase 3 · not yet recruiting A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06818955Phase 2 · not yet recruiting Orlistat Overcoming Third-generation EGFR-TKI Resistance · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03371381Phase 1/Phase 2 · terminated An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588064NA · completed 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04954885completed Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06793813Phase 2 · recruiting Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014286completed Lung Cancer Mutation Consortium Protocol · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04795245completed Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745830recruiting Lymph Node Pathologic Grading Strategy · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730477enrolling by invitation Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06724263Phase 2 · not yet recruiting A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05403554Phase 1 · recruiting A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05925764recruiting WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012397Phase 2 · terminated Milademetan in Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06645743not yet recruiting Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06313268completed Safety of Effivia®, a Bevacizumab Biosimilar · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06634966Phase 3 · recruiting Segmentectomy for Solid-dominant Lung Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02955758Phase 2 · completed Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619886early Phase 1 · not yet recruiting TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06215885unknown Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04750824completed Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S. · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830812recruiting Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06602661Phase 1 · not yet recruiting Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04173507Phase 2 · completed Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04944173Phase 2 · withdrawn SCION: SABR and Checkpoint Inhibition of NSCLC · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794698completed Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520778Phase 1 · completed Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05849246Phase 2 · terminated The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04770688Phase 1/Phase 2 · completed Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04740047completed Cios Mobile 3D Spin for Robotic Bronchoscopy · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02759835Phase 2 · completed Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441357unknown Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717803Phase 3 · recruiting Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266846Phase 2 · recruiting Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05982574active not recruiting Tumor Microenvironment · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04027946Phase 2 · terminated LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03076164Phase 1/Phase 2 · completed A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06334757Phase 2 · unknown Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06335355Phase 2/Phase 3 · not yet recruiting A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04682431Phase 1 · terminated A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04691375Phase 1 · terminated A Study of PY314 in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310943Phase 2 · completed Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03190239Phase 2 · withdrawn Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer Patients · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03792503Phase 4 · withdrawn Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06255197recruiting Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04046614Phase 1/Phase 2 · completed Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526573unknown Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03646968Phase 2 · unknown Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05318443Phase 3 · completed A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870034early Phase 1 · withdrawn Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031181Phase 3 · recruiting Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03802240Phase 3 · completed Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104709unknown Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05550961recruiting APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498597Phase 1 · unknown AMT-151 in Patients With Selected Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468985Phase 2 · completed Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06056115NA · recruiting Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06028633Phase 2 · not yet recruiting Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031246Phase 3 · recruiting Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05338619Phase 2 · unknown A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05841472Phase 2 · recruiting Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04012619Phase 1 · completed Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04971187Phase 2 · terminated Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962021Phase 2 · unknown Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838053recruiting Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04959981Phase 1 · completed A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794711unknown Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794724unknown Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04165759completed HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252676completed Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011) · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02980991Phase 2 · completed Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002) · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05527808NA · unknown A Single-arm Exploratory Study of Neoadjuvant Therapy · condition mapped ONTOLOGY_EXACT · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04179890completed The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946712Phase 3 · terminated S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 408 trials mapped (118 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633189Phase 3 · unknown Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396457Phase 2 · unknown Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901 · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02409342Phase 3 · completed A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] · condition mapped ALIAS · 408 trials mapped (118 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |